Knockdown of SLFN5 enhances cellular sensitivity to IFN-induced antiproliferative responses in glioma stem-like cancer cells, making SLFN5 a negative regulator of the IFN-response in glioma cancer cells [52]. The gene discussed is SLFN5; the disease is central nervous system cancer.